Warby Parker (WRBY) Competitors $21.45 +0.11 (+0.52%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends WRBY vs. GKOS, BLCO, STVN, INSP, PRCT, AXNX, NVST, NARI, LIVN, and TMDXShould you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Glaukos (GKOS), Bausch + Lomb (BLCO), Stevanato Group (STVN), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Envista (NVST), Inari Medical (NARI), LivaNova (LIVN), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Warby Parker vs. Glaukos Bausch + Lomb Stevanato Group Inspire Medical Systems PROCEPT BioRobotics Axonics Envista Inari Medical LivaNova TransMedics Group Warby Parker (NYSE:WRBY) and Glaukos (NYSE:GKOS) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, community ranking, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment. Do analysts rate WRBY or GKOS? Warby Parker presently has a consensus target price of $18.18, suggesting a potential downside of 15.24%. Glaukos has a consensus target price of $134.55, suggesting a potential downside of 2.81%. Given Glaukos' stronger consensus rating and higher probable upside, analysts clearly believe Glaukos is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 4 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.67Glaukos 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 Does the MarketBeat Community believe in WRBY or GKOS? Glaukos received 402 more outperform votes than Warby Parker when rated by MarketBeat users. Likewise, 64.51% of users gave Glaukos an outperform vote while only 41.38% of users gave Warby Parker an outperform vote. CompanyUnderperformOutperformWarby ParkerOutperform Votes3641.38% Underperform Votes5158.62% GlaukosOutperform Votes43864.51% Underperform Votes24135.49% Which has more volatility & risk, WRBY or GKOS? Warby Parker has a beta of 1.8, suggesting that its stock price is 80% more volatile than the S&P 500. Comparatively, Glaukos has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Does the media favor WRBY or GKOS? In the previous week, Warby Parker had 6 more articles in the media than Glaukos. MarketBeat recorded 12 mentions for Warby Parker and 6 mentions for Glaukos. Glaukos' average media sentiment score of 0.70 beat Warby Parker's score of 0.46 indicating that Glaukos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 3 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Glaukos 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is WRBY or GKOS more profitable? Warby Parker has a net margin of -4.39% compared to Glaukos' net margin of -42.43%. Warby Parker's return on equity of -8.26% beat Glaukos' return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-4.39% -8.26% -4.37% Glaukos -42.43%-18.99%-11.47% Which has better valuation & earnings, WRBY or GKOS? Warby Parker has higher revenue and earnings than Glaukos. Warby Parker is trading at a lower price-to-earnings ratio than Glaukos, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$669.77M3.26-$63.20M-$0.27-79.44Glaukos$314.71M24.26-$134.66M-$3.02-45.84 Do insiders and institutionals believe in WRBY or GKOS? 93.2% of Warby Parker shares are held by institutional investors. Comparatively, 99.0% of Glaukos shares are held by institutional investors. 26.6% of Warby Parker shares are held by company insiders. Comparatively, 6.4% of Glaukos shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryWarby Parker beats Glaukos on 9 of the 17 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Warby Parker News Delivered to You Automatically Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WRBY vs. The Competition Export to ExcelMetricWarby ParkerOphthalmic goods IndustryMedical SectorNYSE ExchangeMarket Cap$2.18B$11.34B$5.15B$19.84BDividend YieldN/A1.63%5.18%3.51%P/E Ratio-79.4435.3765.5935.07Price / Sales3.265.751,278.7517.75Price / CashN/A17.4239.7021.33Price / Book6.483.096.474.64Net Income-$63.20M$224.33M$119.73M$982.94M7 Day Performance9.94%-3.37%-5.13%-2.12%1 Month Performance32.82%-0.01%-2.71%-0.39%1 Year Performance95.00%15.39%31.08%23.34% Warby Parker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WRBYWarby Parker2.3701 of 5 stars$21.45+0.5%$18.18-15.2%+95.7%$2.18B$669.77M-79.443,491Gap UpGKOSGlaukos3.7657 of 5 stars$138.44-0.1%N/A+113.7%$7.63B$314.71M-45.84780Upcoming EarningsShort Interest ↑BLCOBausch + Lomb2.4642 of 5 stars$19.68+0.6%N/A+25.4%$6.93B$4.68B-18.7413,300Short Interest ↓Positive NewsSTVNStevanato Group1.57 of 5 stars€19.00-7.3%N/A-28.4%$6.06B$1.09B40.435,635INSPInspire Medical Systems4.9209 of 5 stars$172.70-0.1%N/A+20.5%$5.18B$624.80M161.401,011Positive NewsPRCTPROCEPT BioRobotics2.5736 of 5 stars$88.94+3.5%N/A+165.7%$4.64B$199.84M-45.61626Analyst ForecastAXNXAxonics3.1087 of 5 stars$70.98flatN/AN/A$3.63B$366.38M-591.45610Short Interest ↑News CoverageNVSTEnvista3.6925 of 5 stars$20.57+2.4%N/A-10.9%$3.54B$2.57B-2.6512,800Short Interest ↓NARIInari Medical3.3224 of 5 stars$50.56+2.7%N/A-14.3%$2.96B$574.50M-37.451,300Positive NewsLIVNLivaNova4.0183 of 5 stars$52.10-0.4%N/A+10.3%$2.83B$1.15B124.052,900Analyst ForecastNews CoverageTMDXTransMedics Group4.3148 of 5 stars$80.48-8.9%N/A+20.6%$2.70B$401.09M85.62210Short Interest ↑High Trading Volume Related Companies and Tools Related Companies GKOS Competitors BLCO Competitors STVN Competitors INSP Competitors PRCT Competitors AXNX Competitors NVST Competitors NARI Competitors LIVN Competitors TMDX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:WRBY) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Warby Parker Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Warby Parker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
